Results 71 to 80 of about 20,043 (161)

Kaempferol from <i>Moringa oleifera</i> L. increases longevity and ameliorates efavirenz-induced functional senescence in <i>Drosophila melanogaster</i>. [PDF]

Toxicol Rep
Iorjiim WM, Makwin LL, Ipav SS, Omale S.
europepmc   +1 more source

CYP46A1-Targeted Treatment Alleviates Long-Term White Matter Injury Following Traumatic Brain Injury by Promoting Cholesterol Metabolic Clearance and Remyelination. [PDF]

CNS Neurosci Ther
Li L, Shi Y, Luo Q, Guo P, Jin T, Ru X, Jiang Z, Niu Y, Li W, Chen Y, Chen Z.   +10 more
europepmc   +1 more source

The Effect of Efavirenz and Rufinamide on the Pharmacokinetics and Safety of Quizartinib: Two Phase 1 Studies in Healthy Participants. [PDF]

Clin Transl Sci
Yoo Y, Zahir H, Inaba S, Koo K, Garimella T, Abutarif M, Zheng M, Kamiyama E, Xu Y.   +8 more
europepmc   +1 more source

One- and Two-Year Outcomes of Switching to a Dolutegravir-Based ART Regimen: An Observational Emulation of Sequential Target Trials. [PDF]

Open Forum Infect Dis
Zheng A, Murray EJ, Brennan AT, Greener R, Kileel EM, Bor J, Venter WDF, Pisa PT, Fox MP, Maskew M.   +9 more
europepmc   +1 more source

The impact of dolutegravir on the growth of HIV-exposed uninfected infants: an observational cohort study in rural Tanzania. [PDF]

EClinicalMedicine
Glanzmann S, Luoga E, Okuma J, Dotto E, Sigalla G, Franzeck FC, Nyenza E, Mnzava D, Bukuku M, Moshi L, Wilson L, Paris DH, Glass TR, Mollel GJ, Weisser M, Vanobberghen F, KIULARCO Study Group.   +16 more
europepmc   +1 more source

Physiologically Based Pharmacokinetic Modeling to Assess Antiretroviral-BTK Inhibitor Interactions and Provide Recommendations for Co-Administration Regimens. [PDF]

Pharmaceutics
Chen L, Wang X, Li L, Yang Y, Liu Y, Chen W.   +5 more
europepmc   +1 more source

Initiation of dolutegravir vs efavirenz on 12- and 24-month weight, body mass index, blood pressure, and incident hypertension: A target trial emulation. [PDF]

Ann Epidemiol
Zheng A, Fox MP, Greener R, Kileel EM, Bor J, Venter WD, Pisa PT, Murray EJ, Brennan AT, Maskew M.   +9 more
europepmc   +1 more source

Efavirenz and CYP2C9 Genetic Polymorphisms Reduce CYP2C9 Activity in Healthy Participants. [PDF]

Clin Transl Sci
Kim JD, Metzger IF, Lu JBL, Skaar TC, Desta Z.   +4 more
europepmc   +1 more source

Efavirenz metabolism and CNS toxicity in Ugandan children: impact of CYP2B6 genotype and plasma metabolite profiles. [PDF]

Front Pharmacol
Soeria-Atmadja S, Pettersson Bergstrand M, Amuge P, Nanzigu S, Bbuye D, Rubin J, Kekitiinwa A, Obua C, Dahl ML, Pohanka A, Gustafsson LL, Navér L, Eriksen J.   +12 more
europepmc   +1 more source

Development and Validation of Bioanalytical Method for Efavirenz in Dried Blood Spot Using High Performance Liquid Chromatography-Photodiode Array. [PDF]

J Exp Pharmacol
Putri DN, Harahap Y, Saputri FA.
europepmc   +1 more source